湖北英纳氏生物科技有限公司

湖北英纳氏生物科技有限公司

湖北省武汉市江夏区东湖高新国际大健康城

2020

40至49

不愿意公开

湖北英纳氏生物科技有限公司是一家在小分子化学药物领域，为药物研发与产业化机构提供研发与产业化服务的CDMO（合同研发生产）企业。公司现有业务包括原料药（API），医药中间体和绿色化学相关工艺的研发和生产。公司主要产品包括：外用非甾体消炎杀菌类小分子药物本维莫德及其相关中间体，防脱固发生发产品克赛、可比落、米诺地尔及其相关中间体，荧光染料/示踪剂D-荧光素及长链碳菁类，组成核酸药物递送系统——纳米脂质颗粒（LNPs）的关键组分的阳离子脂质体SM-102、Lipid 5、ALC-0315及相关产品，以及利用自有流动化学连续流微反应技术生产的含氟苯酚类分子砌块、咪唑杂环类分子砌块等。公司着眼于全球绿色化学的可持续性发展，大力开发和推广医药、农药及其他精细化工行业的流动化学工艺，新建了适应不同生产能力的流动化学实验室，另外配套年流通2000吨的连续流微通道反应器设备和生产车间，可实现流动化学从小试、中试到商业化生产的一条龙服务，从工艺到设备的一站式服务。

经验丰富的研发人员,良好的信誉,优质服务

213004

制造商

北美洲,中/南美洲,西欧

Benvitimod/Tapinarof(79338-84-4);Minoxidil(55921-65-8);Kopyrrol(55921-65-8);Kopexil(74638-76-9);D-Luciferin sodium salt(103404-75-7);D-Luciferin potassium salt(115144-35-9);D-Luciferin(2591-17-5);5-Fluoro-D-Luciferin potassium(916661-57-9);Lipid 5(2089251-33-0);LC 13(2089251-49-8);ALC-0315(2036272-55-4);SM-102(2089251-47-6);Methyl 4-isopropyl-3,5-dimethoxybenzoate(344396-17-4);(4-isopropyl-3,5-dimethoxyphenyl)methanol(344396-18-5);4-isopropyl-3,5-dimethoxybenzaldehyde(344396-19-6);3,5-dimethoxy-4-isopropylbenzyl bromide(443982-75-8);Diethyl 4-isopropyl-3,5-dimethoxybenzylphosphonate(443982-76-1);3,5-Dimethoxy-4-isopropyl-trans-stilbene(141509-20-8);3,5-Dihydroxy-4-isopropylstilbene(79338-84-4);4-isopropyl-3,5-dimethoxybenzoic acid(55703-81-6);6-undecanol (23708-56-7);6-Undecanone (927-49-1);7-Tridecanol (927-45-7);7-tridecanone (462-18-0);8-Pentadecanol (1653-35-6);8-pentadecanone (818-23-5);9-Heptadecanol (624-08-8);9-Heptadecanone (540-08-9);10-Nonadecanol (16840-84-9);10-nonadecanone (504-57-4);11-Heneicosanol (3381-26-8);11-Henicosanone (19781-72-7);4-Trifluoromethylphenol(402-45-9);4-Trifluoromethoxyphenol(828-27-3);2,3-Difluorophenol(6418-38-8);2,4-Difluorophenol(367-27-1);2,5-Difluorophenol(2713-31-7);2,6-Difluorophenol(28177-48-2);3,4-Difluorophenol(2713-33-9);3,5-Difluorophenol(2713-34-0);Ilaprazole (172152-36-2);4-Chloro-2,3-dimethylpyridine N-oxide (59886-90-7);4-Chloro-2,3,5-trimethylpyridine N-oxide (109371-20-2);3,4-Dimethoxy-2-Methyl Pyridine N-Oxide (72830-07-0);4-Methoxy-2,3,5-trimethylpyride-N-oxide (86604-80-0);2,3-Dimethyl-4-methoxypyridine N-oxide (102625-96-7);2,6-Diamino-4-chloropyrimidine 1-oxide (35139-67-4);Boc-Gly-Pro-OH(14296-92-5);Undecyl 6-Bromohexanoate(959040-06-3);Nonyl 8-bromo-octanoate(2089253-38-1);6-((2-hydroxyethyl)amino)hexanoate(2695624-37-2);8-((2-hydroxyethyl)amino)octanoate(2089253-37-0);3,3’-dioctadecyloxacarbocyanine perchlorate (DiOC18(3)) (34215-57-1);4-[4-(Dihexadecylamino)styryl]-N-methylpyridinium iodide; DiA (4-Di-16-ASP)(114041-00-8);1,1'-Dioctadecyl-3,3,3',3'-tetramethylindo carbocyanine perchlorate(DiIC18(3))(41085-99-8);1,1'-Dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine perchlorate((DiIC18(5)) (127274-91-3);1,1'-Dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine iodide(DiC18(5))(75539-51-4);1,1'-Dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide((DiIC18(7))(100068-60-8);1,1'-dihexadecyl-3,3,3',3'-tetramethylindo carbocyanine perchlorate(DiIC16(3))(84109-11-5);1,1'-didodecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate((DiIC12(3))(75664-01-6);4-(4-(didecylamino)styryl)-N-methylpyridinium iodide(4-Di-10-ASP)(95378-73-7);4-(4-(Dihexadecylamino)styryl)-N-methylpyridinium iodide(DiA (4-Di-16-ASP))(114041-00-8);GLY-PRO-HYP-OH(2239-67-0);Z-GLY-PRO-OH(1160-54-9)

第二十三届世界制药原料中国展

2025-03-06至2025-07-31

E7F36

Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;CMO & CRO